FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367309216> ?p ?o ?g. }

• W4367309216 endingPage "219" @default.
• W4367309216 startingPage "214" @default.
• W4367309216 abstract "Central sensitization (CS) is a condition characterised by (associated with) neuroplastic changes in nociceptive neurons, sub-threshold afferent input, pain hypersensitivity and development widespread pain. Insufficient response to disease-modifying antirheumatic drugs (DMARDs) can be caused by CS. Objective – to evaluate the features of clinical manifestations of RA in patients with ineffective antirheumatic therapy, depending on the presence of signs of CS. Material and methods. The study group included 509 patients diagnosed with RA (according to ACR/EULAR classification criteria, 2010) with moderate or high disease activity (DAS28-CRP≥3.2) and ineffectiveness or intolerance of conventional synthetic DMARDs, biological DMARDs and JAK inhibitors. Disease activity in patient with RA was assessed by DAS28-CRP. Our study did not include an examination by a neurologist to detect signs of CS, so the Central Sensitization Inventory (CSI) (part one) was used. The BPI questionnaire was used for assessing clinical pain intensity. The PainDETECT, FSS, FIRST, HAQ questionnaires were used for screening neuropathic pain symptoms (NPS), fatigue, fibromyalgia signs and functional impairment, respectively. The HADS questionnaire was recommended for early diagnosis anxiety and depression disorders. Results. Signs of CS (CSI≥40), with a median of 42 [32; 53], were found in 57.2% of the examined patient. Patients with signs of CS were established to have poorer health measure (PGA – 64.6±13.5 and 53.5±16.8; p =0.001), higher pain intensity in all BPI scales, longer morning stiffness – 90 [30; 180] and 60 [20; 120] minutes ( p =0.001), more painful joints – 8 [5; 12] and 7 [4; 10] ( p =0.005), worse functional status in HAQ (1.65±0.7 and 1.08±0.5; p =0.001) and higher disease activity in DAS28-CRP (4.9±1.0 and 4.6±0.9; p =0.001) compared to patients without signs of CS. There was also direct correlation between CS and a high frequency of having an NPS (PainDETECT>18) – 34.5% and 10.3% ( p =0.001), significant anxiety and depression (HADS>11) – 29,0% and 5.1% ( p =0.001) and 26.3% and 4.2% ( p =0.001) respectively, fatigue (FSS) – 96.5% and 70.4% ( p =0.001), signs of fibromyalgia (FIRST≥5) – 38.4% and 6.1% ( p =0.001). Conclusion. The presence of signs of CS in patient with RA significantly enhance many symptoms of disease, being associated with higher pain intensity, fatigue, impaired function, higher incidence of NPS, depression and anxiety, and fibromyalgia." @default.
• W4367309216 created "2023-04-29" @default.
• W4367309216 creator A5000954559 @default.
• W4367309216 creator A5001605289 @default.
• W4367309216 creator A5004963520 @default.
• W4367309216 creator A5007010542 @default.
• W4367309216 creator A5022781264 @default.
• W4367309216 creator A5034283904 @default.
• W4367309216 creator A5047421494 @default.
• W4367309216 creator A5057275283 @default.
• W4367309216 creator A5059457275 @default.
• W4367309216 creator A5068868398 @default.
• W4367309216 creator A5073029849 @default.
• W4367309216 date "2023-04-28" @default.
• W4367309216 modified "2023-09-29" @default.
• W4367309216 title "Features of clinical manifestations of rheumatoid arthritis in patients after failure of conventional synthetic disease-modifying antirheumatic drugs therapy depending on the signs of central sensitization" @default.
• W4367309216 cites W2016950635 @default.
• W4367309216 cites W2116230226 @default.
• W4367309216 cites W2612386931 @default.
• W4367309216 cites W2622000437 @default.
• W4367309216 cites W2731869602 @default.
• W4367309216 cites W2945811659 @default.
• W4367309216 cites W2953686451 @default.
• W4367309216 cites W3084960147 @default.
• W4367309216 cites W3118696437 @default.
• W4367309216 cites W3131922048 @default.
• W4367309216 cites W3135686821 @default.
• W4367309216 cites W3164319011 @default.
• W4367309216 cites W3171986361 @default.
• W4367309216 cites W3179165217 @default.
• W4367309216 cites W3198009313 @default.
• W4367309216 cites W3207061275 @default.
• W4367309216 cites W4211054359 @default.
• W4367309216 cites W4214955092 @default.
• W4367309216 cites W4225146322 @default.
• W4367309216 cites W4310956709 @default.
• W4367309216 doi "https://doi.org/10.47360/1995-4484-2023-214-219" @default.
• W4367309216 hasPublicationYear "2023" @default.
• W4367309216 type Work @default.
• W4367309216 citedByCount "0" @default.
• W4367309216 crossrefType "journal-article" @default.
• W4367309216 hasAuthorship W4367309216A5000954559 @default.
• W4367309216 hasAuthorship W4367309216A5001605289 @default.
• W4367309216 hasAuthorship W4367309216A5004963520 @default.
• W4367309216 hasAuthorship W4367309216A5007010542 @default.
• W4367309216 hasAuthorship W4367309216A5022781264 @default.
• W4367309216 hasAuthorship W4367309216A5034283904 @default.
• W4367309216 hasAuthorship W4367309216A5047421494 @default.
• W4367309216 hasAuthorship W4367309216A5057275283 @default.
• W4367309216 hasAuthorship W4367309216A5059457275 @default.
• W4367309216 hasAuthorship W4367309216A5068868398 @default.
• W4367309216 hasAuthorship W4367309216A5073029849 @default.
• W4367309216 hasBestOaLocation W43673092161 @default.
• W4367309216 hasConcept C126322002 @default.
• W4367309216 hasConcept C139719470 @default.
• W4367309216 hasConcept C162324750 @default.
• W4367309216 hasConcept C1862650 @default.
• W4367309216 hasConcept C203014093 @default.
• W4367309216 hasConcept C2776217527 @default.
• W4367309216 hasConcept C2776867660 @default.
• W4367309216 hasConcept C2777575956 @default.
• W4367309216 hasConcept C2777831278 @default.
• W4367309216 hasConcept C2779134260 @default.
• W4367309216 hasConcept C2908564923 @default.
• W4367309216 hasConcept C2909063479 @default.
• W4367309216 hasConcept C71924100 @default.
• W4367309216 hasConceptScore W4367309216C126322002 @default.
• W4367309216 hasConceptScore W4367309216C139719470 @default.
• W4367309216 hasConceptScore W4367309216C162324750 @default.
• W4367309216 hasConceptScore W4367309216C1862650 @default.
• W4367309216 hasConceptScore W4367309216C203014093 @default.
• W4367309216 hasConceptScore W4367309216C2776217527 @default.
• W4367309216 hasConceptScore W4367309216C2776867660 @default.
• W4367309216 hasConceptScore W4367309216C2777575956 @default.
• W4367309216 hasConceptScore W4367309216C2777831278 @default.
• W4367309216 hasConceptScore W4367309216C2779134260 @default.
• W4367309216 hasConceptScore W4367309216C2908564923 @default.
• W4367309216 hasConceptScore W4367309216C2909063479 @default.
• W4367309216 hasConceptScore W4367309216C71924100 @default.
• W4367309216 hasIssue "2" @default.
• W4367309216 hasLocation W43673092161 @default.
• W4367309216 hasOpenAccess W4367309216 @default.
• W4367309216 hasPrimaryLocation W43673092161 @default.
• W4367309216 hasRelatedWork W2045151582 @default.
• W4367309216 hasRelatedWork W2062195538 @default.
• W4367309216 hasRelatedWork W2082406232 @default.
• W4367309216 hasRelatedWork W2156283049 @default.
• W4367309216 hasRelatedWork W2316954211 @default.
• W4367309216 hasRelatedWork W2326094713 @default.
• W4367309216 hasRelatedWork W2427075784 @default.
• W4367309216 hasRelatedWork W2617939361 @default.
• W4367309216 hasRelatedWork W2761967325 @default.
• W4367309216 hasRelatedWork W4210646529 @default.
• W4367309216 hasVolume "61" @default.
• W4367309216 isParatext "false" @default.
• W4367309216 isRetracted "false" @default.
• W4367309216 workType "article" @default.